Ra Capital Management, L.P. Vaxart, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.56 - $1.41 $8.62 Million - $21.7 Million	15,384,615 New	15,384,615 $20 Million
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $15.5 Million - $64 Million	-2,742,271 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.5 - $7.98 $28.2 Million - $64.4 Million	-8,068,666 Reduced 74.63%	2,742,271 $15.7 Million
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $51.7 Million - $183 Million	10,810,937 New	10,810,937 $71.9 Million

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.